Abstract

Thyroid cancer is the most common malignancy of endocrine glands, and over 37,000 new cases are predicted for 2008. Although most patients diagnosed with thyroid cancer will not die from this disease, a significant proportion of patients will develop recurrent or metastatic disease, and mutations in the gene encoding the serine/threonine l

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32CA142150-01
Application #
7749620
Study Section
Special Emphasis Panel (ZRG1-F06-E (20))
Program Officer
Jakowlew, Sonia B
Project Start
2009-09-01
Project End
2010-08-31
Budget Start
2009-09-01
Budget End
2010-08-31
Support Year
1
Fiscal Year
2009
Total Cost
$59,402
Indirect Cost

  Institution

Name
Massachusetts Institute of Technology
Department
Internal Medicine/Medicine
Type
Schools of Arts and Sciences
DUNS #
001425594
City
Cambridge
State
MA
Country
United States
Zip Code
02139